These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39111103)

  • 1. Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience.
    Dono F; Evangelista G; Rodorigo D; Rollo E; Romozzi M; Corniello C; Liviello D; Dasara M; Capriati L; Quintieri P; Servidei S; Della Marca G; Calabresi P; Sensi SL; Vollono C
    Epilepsy Behav; 2024 Oct; 159():109951. PubMed ID: 39111103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study.
    Rollo E; Romozzi M; Dono F; Bernardo D; Consoli S; Anzellotti F; Ricciardi L; Paci L; Sensi SL; Della Marca G; Servidei S; Calabresi P; Vollono C
    Epilepsy Behav; 2023 Mar; 140():109093. PubMed ID: 36739634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
    Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
    Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses.
    Jain P; Aneja S; Cunningham J; Arya R; Sharma S
    Seizure; 2022 Nov; 102():74-82. PubMed ID: 36209676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012-2021) from a University Hospital in Germany.
    Purwien L; Schubert-Bast S; Kieslich M; Ronellenfitsch MW; Merker M; Czabanka M; Willems LM; Rosenow F; Strzelczyk A
    CNS Drugs; 2023 Nov; 37(11):993-1008. PubMed ID: 37979095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
    Naeem B; Ashfaq M; Qureshi MA
    J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New onset status epilepticus and its long-term outcome: A cohort study.
    Adiga S; Mundlamuri RC; Asranna A; Vishwanathan LG; Raghavendra K; Nanjaiah ND; Prathyusah PV; Kulanthaivelu K; Sinha S
    Epilepsy Res; 2024 Oct; 206():107442. PubMed ID: 39208568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of levetiracetam and phenytoin in the treatment of established status epilepticus: A systematic review and meta-analysis.
    Yang L; Dong XZ; Cui XH; Liu JM; Liu WN; Zhang L
    J Clin Neurosci; 2021 Jul; 89():422-429. PubMed ID: 34053822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
    Alvarez V; Januel JM; Burnand B; Rossetti AO
    Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Antiepileptic Approaches in Treatment of Benzodiazepine Nonresponsive Status Epilepticus.
    Bachhuber A; Lasrich M; Halmer R; Fassbender K; Walter S
    CNS Neurosci Ther; 2016 Mar; 22(3):178-83. PubMed ID: 26841716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial.
    Coralic Z; Kapur J; Olson KR; Chamberlain JM; Overbeek D; Silbergleit R
    Ann Emerg Med; 2022 Sep; 80(3):194-202. PubMed ID: 35718575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice variations in the management of status epilepticus.
    Cook AM; Castle A; Green A; Lesch C; Morrison C; Rhoney D; Parker D; Tesoro E; Brophy G; Goodwin H; Gokun J; Makii J; McAllen K; Bledsoe K; Sangha K; Weant K; Liang N; Murphy-Human T;
    Neurocrit Care; 2012 Aug; 17(1):24-30. PubMed ID: 22565631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
    Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
    Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of second-line anticonvulsant agents with adult status epilepticus: A systematic review and network meta-analysis.
    Kishihara Y; Yasuda H; Kashiura M; Amagasa S; Shinzato Y; Moriya T
    Am J Emerg Med; 2024 Aug; 82():183-189. PubMed ID: 38941904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from the Established Status Epilepticus Treatment Trial.
    Cock HR; Coles LD; Elm J; Silbergleit R; Chamberlain JM; Cloyd JC; Fountain N; Shinnar S; Lowenstein D; Conwit R; Bleck TP; Kapur J
    Epilepsy Behav; 2019 Dec; 101(Pt B):106296. PubMed ID: 31653603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.